Literature DB >> 1020588

Indications for surgery in the elderly patient with primary hyperparathyroidism.

A Alveryd, H Boström, B Wengle, P O Wester.   

Abstract

The major symptoms presented by the elderly patient with primary hyperparathyroidism (HPT) were studied in 30 patients, all of whom were over 70 years of age (70-89). Neuromuscular symptoms, fatigue or mental symptoms were the main complaint in 14 patients. Nephrolithiasis, pancreatitis, skeletal changes or thyroid diseases were associated with HPT in 13 patients. Three patients were considered to be asymptomatic. Seven out of the eight patients with neuromuscular symptoms, and two of the three patients with extreme fatigue as the dominant symptom, improved postoperatively. This study indicates that for elderly patients with HPT especially when associated with neuromuscular symptoms or fatigue, surgical therapy is the treatment of choice.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1020588

Source DB:  PubMed          Journal:  Acta Chir Scand        ISSN: 0001-5482


  5 in total

Review 1.  Hyperparathyroidism in the elderly patient.

Authors:  Rebecca Sims; Charanjeit Ubhi; David Hosking
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

2.  Psychiatric morbidity in primary hyperparathyroidism.

Authors:  S J McAllion; C R Paterson
Journal:  Postgrad Med J       Date:  1989-09       Impact factor: 2.401

3.  The influence of surgery on the risk of death in patients with primary hyperparathyroidism.

Authors:  G Hedbäck; A Odén; L E Tisell
Journal:  World J Surg       Date:  1991 May-Jun       Impact factor: 3.352

4.  Surgery for sporadic primary hyperparathyroidism in the elderly.

Authors:  U Ohrvall; G Akerström; S Ljunghall; E Lundgren; C Juhlin; J Rastad
Journal:  World J Surg       Date:  1994 Jul-Aug       Impact factor: 3.352

5.  Surgical treatment of primary hyperparathyroidism in the elderly.

Authors:  D A Heath; A D Wright; A D Barnes; G D Oates; N J Dorricott
Journal:  Br Med J       Date:  1980-06-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.